Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

34.11B

Market cap34.11B

Price-Earnings ratio

35.36

Price-Earnings ratio35.36

Dividend yield

—

Dividend yield—

Average volume

1.94M

Average volume1.94M

High today

$205.93

High today$205.93

Low today

$192.84

Low today$192.84

Open price

$203.33

Open price$203.33

Volume

4.10M

Volume4.10M

52 Week high

$205.93

52 Week high$205.93

52 Week low

$88.00

52 Week low$88.00

Stock Snapshot

With a market cap of 34.11B, Illumina(ILMN) trades at $205.02. The stock has a price-to-earnings ratio of 35.36.

As of 2026-08-01, Illumina(ILMN) stock has fluctuated between $192.84 and $205.93. The current price stands at $205.02, placing the stock +6.3% above today's low and -0.4% off the high.

Illumina(ILMN) shares are trading with a volume of 4.1M, against a daily average of 1.94M.

During the past year, Illumina(ILMN) stock moved between $88.00 at its lowest and $205.93 at its peak.

ILMN News

Simply Wall St 14h

Illumina Stock Climbs On Clinical Growth Despite Margin Pressure - simplywall.st

...

TipRanks 24h

Illumina price target raised to $230 from $170 at RBC Capital

RBC Capital raised the firm’s price target on Illumina (ILMN) to $230 from $170 and keeps an Outperform rating on the shares. The company’s Q2 results are balan...

The Motley Fool 2d

Illumina Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer -...

Analyst ratings

52%

of 23 ratings

Buy

52.2%

Hold

26.1%

Sell

21.7%

More ILMN News

Nasdaq 2d

Illumina Q2 26 Earnings Conference Call At 4:30 PM ET

(RTTNews) - Illumina Inc. (ILMN) will host a conference call at 4:30 PM ET on July 30, 2026, to discuss Q2 26 earnings results. To access the live webcast, log...

Simply Wall St 4d

How Illumina’s Billion Cell Atlas Expansion Could Reshape Eli Lilly’s Drug Discovery Edge

In July 2026, Illumina announced that its Billion Cell Atlas alliance, originally launched with AstraZeneca, Merck, and Eli Lilly, had expanded to include three...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.